For research use only. Not for therapeutic Use.
Lucel 6（Cat No.:I031091）is an experimental biologic therapy being studied for its potential in treating autoimmune diseases, particularly rheumatoid arthritis and multiple sclerosis. It works by modulating immune system activity, targeting specific immune cells involved in inflammation and tissue damage. Lucel 6 is designed to reduce the overactive immune response, helping to control symptoms and prevent disease progression. Early preclinical studies have shown promising results, but its safety and long-term efficacy in humans are still under investigation. Further clinical trials are needed to assess its potential as a treatment for autoimmune conditions.
| CAS Number | 54043-65-1 |
| Synonyms | Lucel 6; Lucel6; Lucel-6 |
| Molecular Formula | C10H20N2O |
| Purity | 98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 1-(tert-butyldiazenyl)cyclohexan-1-ol |
| InChI | InChI=1S/C10H20N2O/c1-9(2,3)11-12-10(13)7-5-4-6-8-10/h13H,4-8H2,1-3H3 |
| InChIKey | VZOZJPYUNZSWAC-UHFFFAOYSA-N |
| SMILES | CC(C)(C)N=NC1(CCCCC1)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
